Aratana Therapeutics' stockholders adopt merger agreement with Elanco Animal Health
Aratana Therapeutics reported 72% (35,269,237) of the Company's common stock outstanding as of the July 14, 2019 record date adopted the merger agreement. Aratana stockholders will receive 0.1481 share of Elanco common stock and one contingent value right for each share of Aratana common stock. July 16, 2019